21
Participants
Start Date
April 30, 2011
Primary Completion Date
February 17, 2014
Study Completion Date
February 17, 2014
Adalimumab and Infliximab
Patients with moderately to severely active Crohn's disease with primary non-response or loss of response to Adalimumab switch to Infliximab.
Sint-Augustinus, Antwerp
UZ Antwerpen, Antwerp
Imelda Hospital, Bonheiden
Cliniques Universitaires Saint-Luc, Brussels
ULB université libre (erasme), Brussels
Ziekenhuis Oost-Limburg, Genk
University Hospital Ghent, Ghent
Virga Jesse hospital, Hasselt
AZ Groeninge, Kortrijk
UZ Leuven, Leuven
CHC (Centre Hospitalier Chrétien), Liège
CHU de liège, Liège
Hospital Maas en kempen, Maaseik
AZ Damiaan, Ostend
Clinique Saint-Pierre, Ottignies
Heilig Hartziekenhuis Roeselare, Roeselare
Collaborators (1)
Abbott
INDUSTRY
University Hospital, Ghent
OTHER